vimarsana.com
Home
Live Updates
New Data Presented at SABCS® 2021 Strengthen Value of O
New Data Presented at SABCS® 2021 Strengthen Value of O
New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San...
Related Keywords
Canada ,
United States ,
San Antonio ,
Texas ,
America ,
Kevin Kalinsky ,
Stephanie Spanos ,
Federico Maiardi ,
Megan Jones ,
Exchange Commission ,
Sciences Corp ,
Genomic Health Inc ,
Facebook ,
Sciences On Twitter Exactsciences ,
Sciences Corporation ,
New England Journal ,
Recurrence Score ,
Princess Margaret Trial ,
Exact Sciences ,
Poster Sessions ,
Spotlight Poster Discussions ,
North East England ,
Using Oncotype ,
Pan Cancer Tissue ,
Genomic Health ,
Risk Factors ,
Annual Report ,
Quarterly Reports ,
Latin America ,
Oral Presentation ,
San Antonio Breast Cancer Symposium ,
Breast Can Res Treat ,
Ann Surg ,
Exact Sciences Corp ,